About Ken Abrahams
Form D filings for Radiance Therapeutics from 2020 to 2023 list Ken Abrahams as director.
Ken Abrahams first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Ken Abrahams in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ken Abrahams works with at each company, as listed on that company's latest Form D.
Radiance Therapeutics, Inc. · Form D/A, Jun 29, 2023
MS
Marc Sandroff
Director
GS
G. Todd Silva
Executive officer
PK
Peng Khaw
Director
LM
Laurence Marsteller
Chief Executive Officer and director